ObjectivesOrganized, population-based cancer screening is recommended by European Union guidelines. Employer-provided screening within Workplace Health Promotion (WHP) programs may differ from evidence-based guidelines. This study aimed to evaluate the alignment between international cancer screening recommendations and screening services offered by companies participating in the Lombardy WHP Program.MethodsA cross-sectional survey was conducted between April and September 2024 among companies participating in the Lombardy WHP Program. Screening practices for breast, cervical, colorectal, prostate, and lung cancer were compared with the most recent international guidelines. Company characteristics were analyzed using descriptive statistics and univariate logistic regression models.ResultsOf the 308 companies participating in the survey, 95 reported the inclusion of preventive medicine services in their corporate welfare offer. Among these, breast cancer screening was the most frequently offered service (67.4%), followed by cervical cancer screening (57.9%). Both the majority of mammography offers (51%) and Pap test offers (92.6%) were not guideline-adherent, thus resulting in overscreening. Colorectal cancer (41.1%) and lung cancer (33.7%) screening were even less commonly provided by the participating companies. Prostate cancer screening with PSA testing was available in 63.2% of participating companies. Large companies had significantly lower odds of inappropriate mammography intervals (OR 0.11; 95% CI 0.02-0.58).ConclusionCancer screening services offered by companies, compliant with the Lombardy WHP Program, are frequently not aligned with current evidence-based recommendations, with overscreening emerging as a predominant issue. Strengthening coordination between occupational health services and public health authorities is essential to ensure appropriate, equitable, and sustainable integration of workplace-based screening initiatives into organized regional cancer prevention strategies.

Adherence to Cancer Screening Guidelines in Employer-Provided Healthcare Programs: A Survey of Companies in Lombardy (Northern Italy) / F. Scovenna, P.B.. - In: CANCER CONTROL. - ISSN 1526-2359. - 33:(2026 Dec), pp. 1-12. [10.1177/10732748261491831]

Adherence to Cancer Screening Guidelines in Employer-Provided Healthcare Programs: A Survey of Companies in Lombardy (Northern Italy)

F. Scovenna
Primo
;
S. Piccinelli;A. Pedot;F. Ferrè;V. Barbera;F.E. Pregliasco
;
D. Cereda
Penultimo
;
S. Deandrea
Ultimo
2026

Abstract

ObjectivesOrganized, population-based cancer screening is recommended by European Union guidelines. Employer-provided screening within Workplace Health Promotion (WHP) programs may differ from evidence-based guidelines. This study aimed to evaluate the alignment between international cancer screening recommendations and screening services offered by companies participating in the Lombardy WHP Program.MethodsA cross-sectional survey was conducted between April and September 2024 among companies participating in the Lombardy WHP Program. Screening practices for breast, cervical, colorectal, prostate, and lung cancer were compared with the most recent international guidelines. Company characteristics were analyzed using descriptive statistics and univariate logistic regression models.ResultsOf the 308 companies participating in the survey, 95 reported the inclusion of preventive medicine services in their corporate welfare offer. Among these, breast cancer screening was the most frequently offered service (67.4%), followed by cervical cancer screening (57.9%). Both the majority of mammography offers (51%) and Pap test offers (92.6%) were not guideline-adherent, thus resulting in overscreening. Colorectal cancer (41.1%) and lung cancer (33.7%) screening were even less commonly provided by the participating companies. Prostate cancer screening with PSA testing was available in 63.2% of participating companies. Large companies had significantly lower odds of inappropriate mammography intervals (OR 0.11; 95% CI 0.02-0.58).ConclusionCancer screening services offered by companies, compliant with the Lombardy WHP Program, are frequently not aligned with current evidence-based recommendations, with overscreening emerging as a predominant issue. Strengthening coordination between occupational health services and public health authorities is essential to ensure appropriate, equitable, and sustainable integration of workplace-based screening initiatives into organized regional cancer prevention strategies.
breast cancer; cancer; cancer screening; colon cancer; colonoscopy; colorectal cancer; early diagnosis; guidelines; hpv; lung cancer
Settore MEDS-24/B - Igiene generale e applicata
dic-2026
4-nov-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
scovenna-et-al-2026-adherence-to-cancer-screening-guidelines-in-employer-provided-healthcare-programs-a-survey-of.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 408.66 kB
Formato Adobe PDF
408.66 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1276980
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact